SERUM TARGETED HILIC-MS METABOLOMICS-BASED ANALYSIS IN INFANTS WITH URETEROPELVIC JUNCTION OBSTRUCTION.
暂无分享,去创建一个
G. Theodoridis | H. Gika | O. Begou | N. Raikos | O. Deda | N. Printza | F. Papachristou | A. Taparkou | J. Dotis | E. Farmaki | A. Pavlaki
[1] S. Stabouli,et al. The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants , 2019, Pediatric Nephrology.
[2] J. Stanslas,et al. Blood and urine biomarkers in chronic kidney disease: An update. , 2019, Clinica chimica acta; international journal of clinical chemistry.
[3] Yan Guo,et al. Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis , 2019, Experimental & Molecular Medicine.
[4] Ying-Yong Zhao,et al. Biomarkers of obstructive nephropathy using a metabolomics approach in rat. , 2018, Chemico-biological interactions.
[5] C. Ching,et al. Common clinical markers predict end-stage renal disease in children with obstructive uropathy , 2018, Pediatric Nephrology.
[6] R. Davies. The metabolomic quest for a biomarker in chronic kidney disease , 2018, Clinical kidney journal.
[7] David S. Wishart,et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis , 2018, Nucleic Acids Res..
[8] I. Wilson,et al. Quality Control and Validation Issues in LC-MS Metabolomics. , 2018, Methods in molecular biology.
[9] R. Coward,et al. The molecular biology of pelvi-ureteric junction obstruction , 2017, Pediatric Nephrology.
[10] M. Weitz,et al. Primary non-surgical management of unilateral ureteropelvic junction obstruction in children: a systematic review , 2017, Pediatric Nephrology.
[11] H. Mischak,et al. Urinary biomarkers for renal tract malformations , 2016, Expert review of proteomics.
[12] Yongyu Zhang,et al. Metabolomics study of renal fibrosis and intervention effects of total aglycone extracts of Scutellaria baicalensis in unilateral ureteral obstruction rats. , 2016, Journal of ethnopharmacology.
[13] J. Schanstra,et al. A capillary electrophoresis coupled to mass spectrometry pipeline for long term comparable assessment of the urinary metabolome , 2016, Scientific Reports.
[14] X. Qin,et al. Kidney Tissue Targeted Metabolic Profiling of Unilateral Ureteral Obstruction Rats by NMR , 2016, Front. Pharmacol..
[15] Liangcai Zhao,et al. Identification of key metabolic changes in renal interstitial fibrosis rats using metabonomics and pharmacology , 2016, Scientific Reports.
[16] Tomoyoshi Soga,et al. Identification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profiling , 2016, Scientific Reports.
[17] Zheng Xiang,et al. The study on serum and urine of renal interstitial fibrosis rats induced by unilateral ureteral obstruction based on metabonomics and network analysis methods , 2016, Analytical and Bioanalytical Chemistry.
[18] Ian D Wilson,et al. Protocol for quality control in metabolic profiling of biological fluids by U(H)PLC-MS. , 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[19] R. Chevalier. Prognostic factors and biomarkers of congenital obstructive nephropathy , 2016, Pediatric Nephrology.
[20] N. Vaziri,et al. Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis , 2015, Scientific Reports.
[21] G. Theodoridis,et al. Development and validation of a HILIC‐MS/MS multitargeted method for metabolomics applications , 2015, Electrophoresis.
[22] P. Brophy,et al. Metabolomics in pediatric nephrology: emerging concepts , 2015, Pediatric Nephrology.
[23] Ian D. Wilson,et al. Advances in liquid chromatography coupled to mass spectrometry for metabolic phenotyping , 2014 .
[24] B. Fernández-Fernández,et al. Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease. , 2014, Kidney international.
[25] David S. Wishart,et al. HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..
[26] I. Wilson,et al. A QC approach to the determination of day-to-day reproducibility and robustness of LC-MS methods for global metabolite profiling in metabonomics/metabolomics. , 2012, Bioanalysis.
[27] H. Mischak,et al. Urinary proteome analysis at 5-year followup of patients with nonoperated ureteropelvic junction obstruction suggests ongoing kidney remodeling. , 2012, The Journal of urology.
[28] E. Want,et al. Liquid chromatography-mass spectrometry based global metabolite profiling: a review. , 2012, Analytica chimica acta.
[29] Ravi Iyengar,et al. Systems biology of kidney diseases. , 2012, Kidney international.
[30] I. Burton,et al. Alterations in urinary metabolites due to unilateral ureteral obstruction in a rodent model. , 2011, Molecular bioSystems.
[31] S. Kiley,et al. Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy , 2010, Pediatric Nephrology.
[32] M. Kilby,et al. Antenatal ultrasound to predict postnatal renal function in congenital lower urinary tract obstruction: systematic review of test accuracy , 2009, BJOG : an international journal of obstetrics and gynaecology.
[33] B. Bright,et al. Operative versus nonoperative management of ureteropelvic junction obstruction in children. , 2009, Urology.
[34] I. Wilson,et al. LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics , 2008 .
[35] D. Stablein,et al. Contributions of the Transplant Registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) * , 2007, Pediatric transplantation.
[36] H. Mischak,et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis , 2006, Nature Medicine.
[37] Guoyao Wu,et al. Glutathione metabolism and its implications for health. , 2004, The Journal of nutrition.
[38] S. Zeisel,et al. Endogenous formation of dimethylamine. , 1985, The Biochemical journal.